Clinical Trial Update: RESOLUTE China RCT [NA]

View source ↗

Summary

Medtronic Vascular's RESOLUTE China randomized trial has completed; the document notes completion but does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis
• Cardiovascular Diseases
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Resolute zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Medtronic Vascular | Conditions: Ischemic Heart Disease, Stenotic Coronary Lesion | NA | Status: COMPLETED